Followers | 9 |
Posts | 695 |
Boards Moderated | 0 |
Alias Born | 09/30/2013 |
Sunday, February 23, 2014 7:18:29 PM
http://patents.justia.com/assignee/cara-therapeutics-inc
My understanding of the main patent that has been quoted on this board and elsewhere relates to development of pain / inflammation medicine that is designed to replicate the effects on marijuana but with the intent of eliminating the "high" that comes with typical marijuana usage and isolate just the therapeutic properties of the THC.
Here also is the company webpage:
http://www.caratherapeutics.com/
Here is a link to information on the guy that seems to be the primary inventor for CARA:
https://search.knodeinc.com/viewProfile.action?profile.profileId=C2520757
Here is a a more searchable publication related to the patent (search for THC):
http://www.google.com/patents/WO2008057608A2?cl=en
Quote from publication:
"73. The pharmaceutical composition according to claim 72, wherein the cannabinoid is one or more of the cannabinoids selected from the group consisting of tetrahydrocannabinol (THC), a THC derivative, levonantradol, marinol, nabilone, rimonabant and savitex."
As mentioned above - it appears based on the publication that one of the cannobinoids that they can utilize within the formulas they have developed is THC. IE, they appear to have patented the use of THC within the framework of Synthetic peptide amides. These synthetic peptide amides from what I understand are designed to provide the anti-inflammatory and also anti-pain effects without the high associated with smoking weed.
Recent CARA News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:10:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:15:55 PM
- Cara Therapeutics Announces Exploration of Strategic Alternatives • GlobeNewswire Inc. • 07/11/2024 11:00:00 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 07/08/2024 08:32:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:16:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 09:12:54 PM
- Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica • GlobeNewswire Inc. • 06/12/2024 08:01:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/07/2024 08:10:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:05:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:28:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:26:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:25:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:24:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:17:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:10:44 PM
- Cara Therapeutics Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/13/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2024 08:15:59 PM
- Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024 • GlobeNewswire Inc. • 05/06/2024 11:00:00 AM
- Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/02/2024 11:00:00 AM
- Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024 • GlobeNewswire Inc. • 03/07/2024 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/06/2024 09:45:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:24:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:19:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:13:52 PM
BARRON'S COVE to Premier at the Hamptons International Film Festival • APHP • Sep 30, 2024 2:56 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM